丙型肝炎病毒慢性感染的临床试验
总计25336个结果
-
Merck Sharp & Dohme LLC撤销
-
Seoul National University Boramae HospitalRoche Pharma AG完全的
-
Bausch Health Americas, Inc.完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur未知
-
Dynavax Technologies CorporationPPD; Synteract, Inc.完全的
-
Merck Sharp & Dohme LLC完全的
-
Alios Biopharma Inc.Vertex Pharmaceuticals Incorporated完全的
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Bristol-Myers Squibb不再可用
-
Janssen R&D Ireland完全的
-
National Opinion Research CenterUniversity of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai; Centers for Disease... 和其他合作者完全的
-
Foundation for Liver ResearchHoffmann-La Roche终止
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals Incorporated完全的
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
ANRS, Emerging Infectious DiseasesFlamel Technologies未知
-
National Center for Complementary and Integrative...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pennsylvania 和其他合作者完全的
-
National Taiwan University HospitalMerck Sharp & Dohme LLC; Schering-Plough未知
-
Bader, Ted, M.D.US Department of Veterans Affairs完全的
-
Bausch Health Americas, Inc.完全的慢性丙型肝炎美国, 西班牙, 意大利, 澳大利亚, 加拿大, 波兰, 波多黎各, 俄罗斯联邦, 阿根廷, 法国, 以色列, 英国
-
Dr. Conrado Fernandez完全的
-
Vertex Pharmaceuticals Incorporated完全的
-
sigma-tau i.f.r. S.p.A.SciClone Pharmaceuticals完全的